Home > Insider Trading > Questcor Pharmaceuticals Inc

Questcor Pharmaceuticals Inc (QCOR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Hedge Fund News: Richard Perry, David Einhorn & Starboard Value LP

Perry Capital, the $10.9 billion hedge-fund firm run by Richard Perry, is betting on the paper and packaging industry anticipating that the value of companies could double if they adopt a new tax structure...

Keep Reading →

July 25th, 2014 - Hedge Funds

Deepak Gulati's Argentiere Capital's Top Stock Picks

Zug, Switzerland-based Argentiere Capital is an alternative investment management firm, which was founded by Deepak Gulati. Mr.

Keep Reading →

July 16th, 2014 - Hedge Funds News

Broadwood Capital Reduces Futher Questcor Pharmaceuticals Inc (QCOR)

In its filing with the Securities and Exchange Commission, Neal C. Bradsher's Broadwood Capital has disclosed further reducing its stake in Questcor Pharmaceuticals Inc (NASDAQ:QCOR).

Keep Reading →

April 10th, 2014 - Hedge Funds News

Hedge Funds' Latest Stock Sales and Purchases

Between Tuesday and Thursday – inclusive- Edward Lampert (ESL Investments and others) sold 1.189 million shares of AutoNation, Inc.

Keep Reading →

February 21st, 2014 - Hedge Funds News

Broadwood Capital Trims Its Stake in Questcor Pharmaceuticals Inc (QCOR)

Neal C. Bradsher's Broadwood Capital has trimmed its stake in Questcor Pharmaceuticals Inc (NASDAQ:QCOR) by selling 20,000 shares.

Keep Reading →

January 28th, 2014 - Hedge Funds News

Supercharge Your Portfolio With 2 Small-Cap Investments

You get the same power when you take two high-flying sectors of the market and combine them into a single exchange-traded fund (ETF).

Keep Reading →

November 6th, 2013 - News

Theravance Inc (THRX): Are Hedge Funds Right About This Stock?

At the moment, there are many indicators investors can use to analyze stocks. Some of the most under-the-radar are hedge fund and insider trading activity.

Keep Reading →

September 12th, 2013 - News

Viropharma Inc (VPHM): Are Hedge Funds Right About This Stock?

If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era lost to time.

Keep Reading →

August 28th, 2013 - News

Celldex Therapeutics, Inc. (CLDX), Dendreon Corporation (DNDN): Why Wall Street Has Turned Against It

Since Dendreon Corporation (NASDAQ:DNDN) reported its second-quarter earnings, the stock has declined 40%.

Keep Reading →

August 28th, 2013 - News

Hedge Funds Aren't Crazy About Charles River Laboratories (CRL) Anymore

In today’s marketplace, there are dozens of gauges shareholders can use to watch stocks. A pair of the most innovative are hedge fund and insider trading movement.

Keep Reading →

August 27th, 2013 - News